2015
DOI: 10.1016/j.jgyn.2015.09.034
|View full text |Cite
|
Sign up to set email alerts
|

Prise en charge des tumeurs du sein bénignes épidémiologiquement rares de type Abrikossoff (tumeur à cellules granuleuses), adénomatose érosive du mamelon, cytostéatonécrose, fibromatose mammaire (tumeur desmoïde), galactocèle, hamartome, hémangiome, lipome, papillomatose juvénile, hyperplasie stromale pseudo-angiomateuse (PASH), et tumeur syringomateuse du mamelon : recommandations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 184 publications
0
3
0
Order By: Relevance
“…The treatment is essentially based on complete surgical removal. There is no consensus on the safety margin to be respected, which varies according to the studies, from 0.5 cm to 3 cm [ 4 ]. Recurrences are frequent (18–29%, 3–6 years), and thoracic muscle and rib involvement is possible.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The treatment is essentially based on complete surgical removal. There is no consensus on the safety margin to be respected, which varies according to the studies, from 0.5 cm to 3 cm [ 4 ]. Recurrences are frequent (18–29%, 3–6 years), and thoracic muscle and rib involvement is possible.…”
Section: Discussionmentioning
confidence: 99%
“…The medical treatment is indicated in case of recurrence and contraindication to surgery or radiotherapy. Antiestrogens have shown some efficacy, even in the absence of an estrogen receptor [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation